about
Ginsenosides from American ginseng: chemical and pharmacological diversityMedicinal Plants Qua Glucagon-Like Peptide-1 Secretagogue via Intestinal Nutrient SensorsGinsenoside Re reduces insulin resistance through inhibition of c-Jun NH2-terminal kinase and nuclear factor-kappaB.Inhibitory effects of ginsenosides on basic fibroblast growth factor-induced melanocyte proliferation.Rapid Identification of Ginseng Cultivars (Panax ginseng Meyer) Using Novel SNP-Based Probes.American ginseng stimulates insulin production and prevents apoptosis through regulation of uncoupling protein-2 in cultured beta cells.Ginseng (Panax quinquefolius) Reduces Cell Growth, Lipid Acquisition and Increases Adiponectin Expression in 3T3-L1 Cells.De novo transcriptome assembly and the identification of gene-associated single-nucleotide polymorphism markers in Asian and American ginseng roots.Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in ratsEffect of Ginseng (Panax ginseng) Berry EtOAc Fraction on Cognitive Impairment in C57BL/6 Mice under High-Fat Diet InducementGinsenoside Re: Its chemistry, metabolism and pharmacokineticsThe aglycone of ginsenoside Rg3 enables glucagon-like peptide-1 secretion in enteroendocrine cells and alleviates hyperglycemia in type 2 diabetic miceEFFECTS OF GINSENG AND ITS FOUR PURIFED GINSENOSIDES (Rb2, Re, Rg1, Rd) ON HUMAN PANCREATIC ISLET β CELL IN VITRO.A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials.Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium.Ginsenoside-Re ameliorates ischemia and reperfusion injury in the heart: a hemodynamics approachDiscrimination of Korean ginseng (Panax ginseng Meyer) cultivar Chunpoong and American ginseng (Panax quinquefolius) using the auxin repressed protein gene.DNA Microarray-Based Screening and Characterization of Traditional Chinese Medicine.Progress in diabetes research in China.Chemical and pharmacological studies of saponins with a focus on American ginsengGinsenoside Re: pharmacological effects on cardiovascular system.Ginseng and diabetes: the evidences from in vitro, animal and human studies.Anti-diabetic potential of Panax notoginseng saponins (PNS): a review.Ginsenoside Re Promotes Osteoblast Differentiation in Mouse Osteoblast Precursor MC3T3-E1 Cells and a Zebrafish Model.Protective effect of ginsenoside Re on acute gastric mucosal lesion induced by compound 48/80.Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.Inhibitory effects of the transgenic Panax ginsengs on phorbol ester plus A23187-induced IL-6 production and cyclooxygenase-2 via suppression of NF-κB and MAPKs in HMC-1.Antioxidant and apoptotic effects of korean white ginseng extracted with the same ratio of protopanaxadiol and protopanaxatriol saponins in human hepatoma HepG2 cells.Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of actionAmerican ginseng modulates pancreatic beta cell activities.Effect of Korean Red Ginseng in chronic liver disease.Ginsenoside profiles and related gene expression during foliation in Panax ginseng Meyer.Preventive effects of protopanaxadiol and protopanaxatriol ginsenosides on liver inflammation and apoptosis in hyperlipidemic apoE KO miceEffect of ginsenosides Rg3 and Re on glucose transport in mature 3T3-L1 adipocytes.Investigation of ginsenosides in different tissues after elicitor treatment in Panax ginseng.Saponins isolated from the root of Panax notoginseng showed significant anti-diabetic effects in KK-Ay mice.Study on the Correlation between Gene Expression and Enzyme Activity of Seven Key Enzymes and Ginsenoside Content in Ginseng in Over Time in Ji'an, China.Comprehensive Profiling and Quantification of Ginsenosides in the Root, Stem, Leaf, and Berry of Panax ginseng by UPLC-QTOF/MS.Efficacy and safety of Panax ginseng berry extract on glycemic control: A 12-wk randomized, double-blind, and placebo-controlled clinical trial.Complete conversion of all typical glycosylated protopanaxatriol ginsenosides to aglycon protopanaxatriol by combined bacterial β-glycosidases.
P2860
Q24630142-CD24AE39-AD74-49DD-9163-F4434B431D76Q26770832-B92AB84D-B7F4-47BF-8497-E3D78A830437Q33643299-3BE6EF94-A336-4B77-A7D6-BF7FAD790E0AQ33849947-21884FFC-6715-4B8E-A283-E6413EF92BECQ34743690-8C84D714-26B0-44D1-9FBF-E0834E9292CDQ34803578-4D75B10C-22E4-4C61-970E-7A5BE75C2270Q35106601-409B97C6-E8EB-4FC2-A3BA-B83369A3DDC9Q35531362-9FFAE71A-E76C-4C72-94B3-3FF608AD8525Q35757149-05651A9C-CFAA-4750-B0A5-5425051D2C80Q35800895-C65698B8-3020-4CC7-981A-2545D47BBCB0Q35811907-384ECC5E-7F37-4BBB-8579-0A915FBC2B97Q36379486-E2914928-FB2B-43B4-8CFF-5B0C4881DDC7Q37191153-8B88BC19-254B-4C9D-8645-B31D60F4CFCCQ37195895-B07DB1C4-FC9D-4932-A810-657E921BF602Q37248847-D4CB1028-500E-4004-9A1A-9D5BA0B10BFBQ37283786-01E58269-C492-43EE-A5A2-98DA25EF032EQ37314411-87225757-CEDA-48EF-8E7B-C0354A54BDE0Q37731217-DE95E26B-C61E-4632-A097-834B7BC643D3Q37798064-4041522B-1B3D-47B4-8100-0D19846C0D2DQ37848089-507F3C00-3544-4CAD-81E8-21A3D057C64BQ37925017-46784237-F77C-478C-B762-D0979F98C984Q38110276-E675A930-EDBD-411D-9CA9-D379E380191AQ38121039-6014142C-2DE7-4025-BDB6-8191F76927F7Q38723595-F07CEEE3-3030-45EE-9EFE-402061198956Q38752226-7D0B562B-6421-4B79-AA10-74176DB47CAAQ39101221-A6A557E9-D9CF-4BD7-BFF5-377005F15BCDQ39686784-3F64838B-F8E9-4E5F-A64D-E0578B409850Q39805448-59C0AE68-88AA-4CD7-9D47-FA62F19AFF49Q39885740-DD47A95C-31B2-4568-A9D4-3C17B6CC4E46Q40660633-E063AA99-06EA-4D6A-ACCB-D194305D35C2Q41918655-6F9D9633-90C5-4A34-8D79-0737AF6954CBQ41919317-8EB20606-806B-41EE-9863-6014459CB7D4Q42034373-37653E40-3E65-4DC1-8253-91630FB453D1Q42811385-2038E659-14A0-455D-B3A5-633F2481D99FQ42968056-84B6AF35-C708-42DE-BAA6-4D8A481CBF00Q46217869-CDF3ACA2-0226-4230-BEBC-DB96FE7D9168Q47257148-1F5B1236-A0B1-4F94-97A4-C49AFD493461Q48174268-9A7950C4-D35F-42B1-9CFD-C945664CAD41Q49389012-1864506F-3DCB-40B9-9C3A-675E02B5C38FQ49721545-813E700D-F9BB-46AB-87CD-5D97584AF5EF
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Anti-diabetic effect of ginsenoside Re in ob/ob mice.
@en
Anti-diabetic effect of ginsenoside Re in ob/ob mice.
@nl
type
label
Anti-diabetic effect of ginsenoside Re in ob/ob mice.
@en
Anti-diabetic effect of ginsenoside Re in ob/ob mice.
@nl
prefLabel
Anti-diabetic effect of ginsenoside Re in ob/ob mice.
@en
Anti-diabetic effect of ginsenoside Re in ob/ob mice.
@nl
P2093
P1476
Anti-diabetic effect of ginsenoside Re in ob/ob mice.
@en
P2093
Chong-Zhi Wang
Chun-Su Yuan
Graeme I Bell
Han H Aung
Jing-Tian Xie
Paul A Rue
Richard Quigg
Sangeeta R Mehendale
Xiaoyu Wang
P304
P356
10.1016/J.BBADIS.2004.10.010
P577
2004-11-05T00:00:00Z